Effectiveness of Lipid-lowering therapy with Bempedoic Acid plus Ezetimibe in a Real-world Cohort

被引：0
|
作者：
Nelson, James
Bloedon, Leanne
Lewandowski, David
Bonafede, Machaon
Sarnes, Evelyn
机构：
来源：
CIRCULATION | 2024年 / 150卷
关键词：
D O I：
10.1161/circ.150.suppl_1.4131775
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4131775
引用
收藏
页数：2
相关论文
共 50 条
  • [21] A Newly Approved Cholesterol Drug Joins the Lipid-Lowering Arsenal: Bempedoic Acid
    Furer, Joseph
    Popova, Olga
    Plakogiannis, Roda
    JNP- THE JOURNAL FOR NURSE PRACTITIONERS, 2020, 16 (10): : 722 - 725
  • [22] Lipid-lowering therapy with Inclisiran in the real-world setting: initial data from a national health care service
    Zafrir, B.
    Naoum, I
    Aker, A.
    Saliba, W.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [23] Lipid-lowering therapy with inclisiran in the real-world setting: Initial data from a national health care service
    Naoum, Ibrahim
    Saliba, Walid
    Aker, Amir
    Zafrir, Barak
    JOURNAL OF CLINICAL LIPIDOLOGY, 2024, 18 (05) : e809 - e816
  • [24] Real-World Effectiveness of Lipid-Lowering Medications on Outcomes after Stroke: Potential Implications of the New-User Design
    Olaiya, Muideen T.
    Andrew, Nadine E.
    Dalli, Lachlan L.
    Ung, David
    Kim, Joosup
    Cadilhac, Dominique A.
    Wood, Peter
    May, Janet
    Clissold, Ben
    Kilkenny, Monique F.
    PRECISE investigators
    NEUROEPIDEMIOLOGY, 2022, 56 (05) : 365 - 372
  • [25] Risk of hospitalized rhabdomyolysis associated with lipid-lowering drugs in a real-world clinical setting
    Cziraky, Mark J.
    Willey, Vincent J.
    McKenney, James M.
    Kamat, Siddhesh A.
    Fisher, Maxine D.
    Guyton, John R.
    Jacobson, Terry A.
    Davidson, Michael H.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2013, 7 (02) : 102 - 108
  • [26] TRENDS IN DISCONTINUATION OF LIPID-LOWERING AND ANTIHYPERTENSIVE THERAPIES: A REAL-WORLD DATA ANALYSIS IN ITALY
    Dovizio, M.
    Perrone, V
    Iacolare, B.
    Andretta, M.
    Bacca, M.
    Barbieri, A.
    Bartolini, F.
    Cavaliere, A.
    Chinellato, A.
    Ciaccia, A.
    Cillo, M. R.
    Costantini, A.
    Dell'Orco, S.
    Ferrante, F.
    Gentile, S.
    Grego, S.
    Lavalle, A.
    Maccio, S.
    Mancini, D.
    Moscogiuri, R.
    Mosele, E.
    Pagliaro, R.
    Pastorello, M.
    Procacci, C.
    Re, D.
    Santoleri, F.
    Ubertazzo, L.
    Vercellone, A.
    Degli Esposti, L.
    VALUE IN HEALTH, 2022, 25 (12) : S285 - S285
  • [27] Real-World Patient Profiles and Lipid-Lowering Efficacy of PCSK9 Inhibitors
    Ma, Tiantian
    Huang, Fengmei
    Yu, Qiuyan
    Chui, Celine S. L.
    Chen, Peiling
    Wong, Ian Chi Kei
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 232 - 233
  • [28] Cost-effectiveness of Ezetimibe plus statin lipid-lowering therapy: A systematic review and meta-analysis of cost-utility studies
    Sasidharan, Akhil
    Bagepally, Bhavani Shankara
    Kumar, S. Sajith
    Jagadeesh, Kayala Venkata
    Natarajan, Meenakumari
    PLOS ONE, 2022, 17 (06):
  • [29] Lipid-lowering therapy with PCSK9-inhibitors in the management of cardiovascular high-risk patients: Effectiveness, therapy adherence and safety in a real world cohort
    Saborowski, Michael
    Doelle, Michael
    Manns, Michael P.
    Leitolf, Holger
    Zender, Steffen
    CARDIOLOGY JOURNAL, 2018, 25 (01) : 32 - 41
  • [30] Effectiveness of hospital lipid-lowering protocol of intensive lipid-lowering therapy for patients with acute coronary syndrome
    Nakao, Sho
    Ishihara, Takayuki
    Tsujimura, Takuya
    Iida, Osamu
    Hata, Yosuke
    Toyoshima, Taku
    Higashino, Naoko
    Mano, Toshiaki
    JOURNAL OF CARDIOLOGY, 2022, 79 (03) : 391 - 399
12345